home / stock / adag / adag articles


ADAG Articles, Adagene Inc.

Stock Information

Company Name: Adagene Inc.
Stock Symbol: ADAG
Market: NASDAQ

Menu

ADAG ADAG Quote ADAG Short ADAG News ADAG Articles ADAG Message Board
Get ADAG Alerts

News, Short Squeeze, Breakout and More Instantly...

Adagene to Present at Investor Conferences in June | Benzinga

SAN DIEGO and SUZHOU, China, May 22, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. ("Adagene") (NASDAQ:ADAG), a company transforming the discovery an...

Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session | Benzinga

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share c...

Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announced a partners...

Why Is Cancer Focused Adagene Stock Plummeting Today? | Benzinga

Adagene Inc (NASDAQ:ADAG) announced data from its presentation at the American Society of Clinical Oncology 2024 Gastrointestinal Cancers...

Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of DatChat, Inc. (NASDAQ: DATS) fell sharply in pre-market trading after announcing a proposed underwritten public offering of common stock...

Adagene To Present Interim Results of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in MSS CRC at ASCO-GI Symposium | Benzinga

- Interim results in MSS CRC suggest that SAFEbody precision masking technology enables a new standard for anti-CTLA-4 therapy at higher, more fre...

Why Getty Images Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Gainers Vericity, Inc. (NASDAQ: VERY) shares climbed 87.4% to $11.12 after iA Financial Group announced it will acquire the company. POINT Biopha...

Adagene to Present at Investor and Scientific Conferences in September | Benzinga

– Adagene's CEO, Dr. Peter Luo, participating in SITC webinar on September 22 focused on essential role of Treg depletion for anti-CTLA-4 t...

Next 10